KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Petmed Express (PETS) EBT (2016 - 2025)

Petmed Express' EBT history spans 16 years, with the latest figure at -$10.5 million for Q4 2025.

  • For Q4 2025, EBT fell 4256.2% year-over-year to -$10.5 million; the TTM value through Dec 2025 reached -$59.2 million, down 3190.23%, while the annual FY2025 figure was -$587000.0, 90.64% up from the prior year.
  • EBT reached -$10.5 million in Q4 2025 per PETS's latest filing, down from -$8.5 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $8.3 million in Q3 2021 to a low of -$34.1 million in Q2 2025.
  • Average EBT over 5 years is -$1.4 million, with a median of $518000.0 recorded in 2021.
  • Peak YoY movement for EBT: skyrocketed 680.1% in 2022, then tumbled 4256.2% in 2025.
  • A 5-year view of EBT shows it stood at $5.5 million in 2021, then plummeted by 103.82% to -$211000.0 in 2022, then crashed by 1153.55% to -$2.6 million in 2023, then surged by 90.85% to -$242000.0 in 2024, then crashed by 4256.2% to -$10.5 million in 2025.
  • Per Business Quant, the three most recent readings for PETS's EBT are -$10.5 million (Q4 2025), -$8.5 million (Q3 2025), and -$34.1 million (Q2 2025).